Catalyst Brief

← Calendar

Readoutin 14d

Jiangsu HengRui Medicine Co., Ltd. — SHR0302 tablets、Placebo

Phase 3 primary completion: To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis.

Date
Dec 2026
Type
Readout
Indication
Psoriatic Arthritis

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Jiangsu HengRui Medicine Co., Ltd.

  1. Dec2026